Showing results (71-80 of 2,810) with videos related to

Sort By:
Pageof 281
Expert Opinion on Drug Safety|November 19, 2024
Examining the safety of belimumab, especially in children: an analysis of real-world pharmacovigilance data from the US FDA adverse event reporting system (FAERS) databaseMingming Li, Ziming Zheng, Jie Li, et al.
Expert Opinion on Drug Safety|November 18, 2024
Increased reporting of accidental overdose with glucagon-like peptide-1 receptor agonists: a population-based studyRoger S McIntyre, Angela T H Kwan
Expert Opinion on Drug Safety|November 19, 2024
Mining and influencing factors analysis of sacituzumab govitecan adverse drug event based on FAERS databaseLiu Yang, Xueyu Duan, Shilin Wu, et al.
Expert Opinion on Drug Safety|February 22, 2025
Safety evaluation of ILaris: a real-world analysis of adverse events based on the FAERS databaseXueliang Yi, Shujie Wu, He He, et al.
Expert Opinion on Drug Safety|February 22, 2025
Safety of dual orexin receptor antagonists: a real-world pharmacovigilance studyYu Sun, Tao Xu, Hongbin Xu
Expert Opinion on Drug Safety|February 20, 2025
Drug-induced hypokalemia: an analytical study based on real-world drug monitoring dataBo Song, Liheng Liu, Shichao Dong, et al.
Expert Opinion on Drug Safety|February 24, 2025
Assessing adverse event burden in chronic lymphocytic leukemia treatment regimens: what's best for patient quality of life?Anna Korycka-Wołowiec, Dariusz Wołowiec, Hanna Ławnicka, et al.
Expert Opinion on Drug Safety|February 24, 2025
Review of studies evaluating the effectiveness of risk minimization measures for oncology medicinal products registered in the European Medicines Agency (HMA-EMA) catalogue: findings and lessons learnedJorge Monteiro, Diogo Almeida, João Paulo Fernandes, et al.
Expert Opinion on Drug Safety|February 14, 2025
Assessing the safety of topical minoxidil through disproportionality analysis of FAERS reportsYanbo Li, Bo Liu, Wei Wu, et al.
Expert Opinion on Drug Safety|February 14, 2025
Safety issues of Donepezil combined with Memantine in Alzheimer's disease population: real-world pharmacovigilanceYi Zeng, Bingshuo Liu, Lisi Zhou, et al.
Pageof 281